Klunk W - Search Results

1

Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II.

Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI, Sweet RA, Cidis Meltzer C, Wisniewski S, Kamboh MI, DeKosky ST. Lopez OL, et al. Among authors: klunk w. Neurology. 2000 Dec 26;55(12):1863-9. doi: 10.1212/wnl.55.12.1863. Neurology. 2000. PMID: 11134386

2

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.

Klunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW. Klunk WE, et al. Neurology. 1992 Aug;42(8):1578-85. doi: 10.1212/wnl.42.8.1578. Neurology. 1992. PMID: 1353623

3

Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ. Pettegrew JW, et al. Among authors: klunk we. Neurobiol Aging. 1995 Jan-Feb;16(1):1-4. doi: 10.1016/0197-4580(95)80001-8. Neurobiol Aging. 1995. PMID: 7723928 Clinical Trial.

4

Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia.

Lopez OL, Larumbe MR, Becker JT, Rezek D, Rosen J, Klunk W, DeKosky ST. Lopez OL, et al. Among authors: klunk w. Neurology. 1994 Jul;44(7):1240-5. doi: 10.1212/wnl.44.7.1240. Neurology. 1994. PMID: 8035923

5

Magnetic resonance spectroscopic changes in Alzheimer's disease.

Pettegrew JW, Klunk WE, Panchalingam K, McClure RJ, Stanley JA. Pettegrew JW, et al. Among authors: klunk we. Ann N Y Acad Sci. 1997 Sep 26;826:282-306. doi: 10.1111/j.1749-6632.1997.tb48480.x. Ann N Y Acad Sci. 1997. PMID: 9329700 Review.

6

Biological markers of Alzheimer's disease.

Klunk WE. Klunk WE. Neurobiol Aging. 1998 Mar-Apr;19(2):145-7. doi: 10.1016/s0197-4580(98)00013-x. Neurobiol Aging. 1998. PMID: 9558151 Review. No abstract available.

7

Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.

Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST. Lopez OL, et al. Among authors: klunk w. Neurology. 1999 Oct 12;53(6):1292-9. doi: 10.1212/wnl.53.6.1292. Neurology. 1999. PMID: 10522887

8

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

Styren SD, Hamilton RL, Styren GC, Klunk WE. Styren SD, et al. Among authors: klunk we. J Histochem Cytochem. 2000 Sep;48(9):1223-32. doi: 10.1177/002215540004800906. J Histochem Cytochem. 2000. PMID: 10950879

9

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI, Sweet RA, Cidis Meltzer C, Wisniewski S, Kamboh MI, DeKosky ST. Lopez OL, et al. Among authors: klunk w. Neurology. 2000 Dec 26;55(12):1854-62. doi: 10.1212/wnl.55.12.1854. Neurology. 2000. PMID: 11134385

10

Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features.

Sweet RA, Hamilton RL, Lopez OL, Klunk WE, Wisniewski SR, Kaufer DI, Healy MT, DeKosky ST. Sweet RA, et al. Among authors: klunk we. Int Psychogeriatr. 2000 Dec;12(4):547-58. doi: 10.1017/s1041610200006657. Int Psychogeriatr. 2000. PMID: 11263720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page